Print

Former Quintiles Transnational Corp. And GlaxoSmithKline (GSK) Executive, Santo J. Costa, Joins Dermatrends Board Of Directors 
10/19/2005 5:11:15 PM

Dermatrends, Inc., a privately held research and development company devoted to transdermal and other drug delivery technologies, has strengthened its board of directors with the addition of Santo J. (Sandy) Costa, former president and chief operating officer of Quintiles Transnational Corporation and a consultant to A.M. Pappas & Associates, a leading venture capital and consulting firm serving the life sciences industry.